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ABSTRACT
The aim of this study was to determine a five-year prevalence trend of substance use 
disorders and the modes of presentation of female drug users in North-Eastern Nigeria. 
It was a retrospective, cross sectional study in which sociodemographic, clinical and 
drug-related data of 2,731 clients who were attended to, at the Federal Neuropsychiatric 
Hospital, Maiduguri over a five year period were extracted from their clinical records. 
The overall prevalence of psychoactive substance use disorders among the female 
participants was 9.3% [n = 253] with rising rates from 8.2% in 2012 to 12.2% in 2016, 
and The prevalence trend shows a statistically significant change (χ2 = 51.764, p = 
< 0.001). One hundred and sixty five [65.2%, 95% C.I. = 45.81 - 79.45] met the ICD-10 
diagnostic criteria for dependence. Codeine-containing cough syrup, 73 [28.8%, 95% C.I. 
= 22.18 - 42.27], and Tramadol, 41 [16.2%, 95% C.I. = 10.24 - 25.18] were the commonest 
substances of abuse. Most of them were either compelled by relatives, 103 [40.71, 95% 
C.I. = 29.46 - 53.17] or were accidentally found to be using drugs at presentation, 58 
[22.92, 95% C.I. = 15.75 - 28.93]. Based on these outcomes, the design and adaptation 
of culturally appropriate and gender-specific educational programmes and stigma-
reduction strategies, are recommended.
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INTRODUCTION
Northern Nigeria is one of the most 
conservative regions of the world mainly 
because of its ethno-religious composi-
tion (Jappah, 2013; Terwase, 2014). De-
spite the relative resistance to external in-
fluences, the abuse of psychoactive sub-
stances, mainly; Cannabis, Tramadol, and 
other stimulants were previously docu-
mented among the populace but almost 
exclusively in males (Gureje, et al., 2007; 
Adamson, et al., 2015; Gudaji, et al., 2016; 
Ibrahim, et al., 2017). However, within 
the last decade, the abuse of psychoac-
tive drugs by females in this sub-region of 
the country assumed a larger dimension 
in the context of the ‘national drug abuse 
epidemic’ (van Etten and Anthony, 2001; 
Becker & Hu, 2008). This emerging drug 
abuse trend among females in Northern 
Nigeria necessitated several pronounce-
ments from policy makers and critical 
stakeholders (Suleiman, 2016; Umoru, 
2017).
Previous research has reported re-
markable gender differences in terms of 
psychoactive substance use disorders; 
with reportedly higher prevalence rates, 
earlier age of onset, tendency to use 
multiple psychoactive substances and ex-
hibition of externalizing behaviors among 
males than in females (Becker, 1999; 
Brady & Randall, 1999). The female drug 
users, on the other hand, are more likely 
to exhibit ‘telescoping’, which is a phe-
nomenon that is characterized by a more 
rapid development of the features of de-
pendence from initiation, a higher risk 
of developing physical and behavioral 
complications, as well as the risk of foetal 
malformations, such as the foetal alco-
hol syndrome (Becker, Perry, and West-
enbroek, 2012; and Substance Abuse and 
Mental Health Services Administration 
(SAMHSA), 2014). Other reported pecu-
liarities of substances use disorders in fe-
males are; the higher tendency of being 
initiated by a partner, increased risk of 
being sexually or physically abused, and 
increased usage in the context of comor-
bid psychiatric diagnoses (Greenfield, et 
al., 2010; Cotto, et al., 2010; Agabio, et 
al., 2016).
In sub-Saharan Africa, the abuse of 
drugs by men is tolerated in some cul-
tures but the use of psychoactive sub-
stances by the womenfolk depicts gross 
moral failure, and it is usually considered 
a taboo (Sorsdahl, Stein, and Myers, 
2012; Paul, et al., 2014). Female drug 
abuse is a subject of intense stigmatiza-
tion in most conservative African soci-
eties like the setting in which this study 
was conducted (Paul, et al., 2014; Florez, 
et al., 2015). Based on anecdotal experi-
ences, the negative societal perception of 
female drug abuse, and the negative con-
sequences the users as well as the care-
givers experience significantly encumber 
the presentation of the clients to conven-
tional treatment centres. Secondly, most 
studies conducted in Nigeria on drug and 
alcohol use disorders were mixed gender 
studies that did not consider the chang-
ing gender trends nor the peculiarities of 
the female clients in terms of advocacy 
and intervention. This is the first hospital-
based study in North-Eastern Nigeria that 
looked at drug use disorders exclusively 
among females. 
This study sought to ascertain; (1) the 
prevalence and pattern of substance use 
disorders among female clients, (2) the 
changing trends of female drug abuse 
within a five year review period, and (3) 






This study was conducted at the drug 
addiction treatment, education, and re-
habilitation (D.A.T.E.R.) unit of the Feder-
al Neuropsychiatric Hospital, Maiduguri 
which is located in North-eastern Nige-
ria. As a matter of hospital policy, any 
client seen in the facility is assessed by 
the therapeutic team which consists of 
a psychiatrist, a clinical psychologist, a 
psychiatric nurse, and a social worker. All 
diagnoses were made according to the 
International Classification of Diseases 
and Health- related Disorders version-10 
(ICD-10) criteria of the World Health 
Organization.
Study Design
This was a retrospective, cross-sec-
tional, non-randomized study. The medi-
cal records of all adult clients with sub-
stance use disorders seen in the hospital 
within the period under review (January, 
2012 to December, 2016) were retrieved 
from the electronic database of the 




The inclusion criteria were; adults be-
tween the ages of 18 and 65 years, with 
an identified ICD-10 diagnosis of sub-
stance use disorder, and an objective evi-
dence of drug use using the multi-panel 
urine drug analysis assay. The exclusion 
criteria were; missing relevant data such 
as clinical diagnoses or absence of urine 
drug analysis results and comorbid physi-
cal illness such as neurocognitive impair-
ment or end-organ damage.
Procedure
Information over a five-year period 
(2012 to 2016), was collected from the 
electronic database which logs the so-
ciodemographic and clinical information 
of all patients attended to at the facility. 
At the first stage, the records of all adult 
clients irrespective of gender, with diag-
nosis of substance use disorders, were 
retrieved. Substance use disorder (SUD) 
is defined by the presence of any of the 
following; acute intoxication, withdrawal 
syndrome, abuse, dependence, or sub-
stance-induced disorder. There were 
2,847 clients identified out of which 2,731 
met the eligibility criteria at the end of 
this stage. In the second stage, the data of 
female clients who met the eligibility cri-
teria were extracted on annual basis and 
the total for the five year study period.
Measures
Sociodemographic data: anonymous, 
precoded and pretested sociodemo-
graphic questionnaires were used to col-
lect the relevant sociodemographic char-
acteristics which included gender, age, 
years of education, occupation, and mari-
tal status.
Clinical and drug-related data: which in-
cluded age at onset of use of psychoac-
tive substance, mode of initiation, the 
psychoactive substance the client is us-
ing, whether or not the client has met the 
ICD-10 criteria for dependence, and the 
modes of presentation were all extracted 
from the clinical records of the clients.
Ethical Consideration
The Institutional Review Board of the 
Federal Neuropsychiatric Hospital, Mai-
duguri reviewed and approved the study 
protocol.
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Data Analysis
Analysis was done using the Statistical 
Package for Social Sciences version 18.0 
(SPSS 18.0). Discrete variables were com-
puted as frequencies and percentages. 
Chi-square ‘test of goodness of fit’ was 
used to determine the association be-
tween frequency and annual variations. 
The confidence interval was set at 95% 
confidence interval, p-value < 0.05 was 
used to denote significance, two-tailed.
RESULTS
A total of 2,847 clinical records of clients 
were retrieved for the period under con-
sideration but only 2,731 met the eligibil-
ity criteria for the study. The remaining 116 
were not included due either to incomplete 
data, absence of urine drug analysis result, 
or being outside the age bracket stipulated 
for the study participants. 
Sociodemographic Profiles of the 
Respondents
Of the total 2,731 study participants, 
there were 253(9.3%) females while the 
remaining 90.7% were males. Over 70% 
of the drug users in both groups fall be-
tween the ages of 18 to 37 years. Almost 
63% of the female participants had less 
than 12 years of education in compari-
son to over 72% of the male study par-
ticipants. Over 73% of the females were 
either unskilled workers or unemployed 
as against 90% of the male participants. 
Over 95% of both groups were either sin-
gle or divorced/separated. These findings 
are presented in table 1.
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Table 1. Sociodemographic Characteristics of the Study Participants
Variables Females n(%) Males n(%) Total n(%)
N = 2731
Age in years [Mean = 26.41yrs+4.78 SD, Range = 18 - 61yrs]
18 - 27 112(44.3) 1215(49.0) 1327(48.6)
28 - 37 83(32.8) 993(40.1) 1076(39.4)
38 - 47 35(13.8) 176(7.1) 211(7.7)
48 - 57 19(7.5) 72(2.9) 91(3.3)
> 58 4(1.6) 22(0.9) 26(1.0)
Years of education [Mean = 8.28yrs + 2.31 SD, Range = 0 - 18yrs]
< 12 years 159(62.8) 1792(72.3) 1951(71.4)
> 12 years 94(37.2) 686(27.7) 780(28.6)
Occupational status
Skilled 3(1.2) 18(0.7) 21(0.8)
Intermediate skilled 17(6.7) 49(2.0) 66(2.4)
Semi-skilled 48(19.0) 144(5.8) 192(7.0)
Unskilled 104(41.1) 1341(54.1) 1445(52.9)
Unemployed 81(32.0) 926(37.4) 1007(36.9)
Marital status
Married 11(4.4) 114(4.6) 125(4.6)
Single 207(81.8) 2289(92.4) 2496(91.4)
Divorce/Separated 35(13.8) 75(3.0) 110(4.0)
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Gender Comparison of Five Years 
Prevalence Trends of Substance Use 
Disorders
The overall prevalence of drug abuse 
reported among females in this study 
is 9.3% (n = 253), while it is 90.7% (n 
= 2478) among males. However, the 
annual prevalence rates from 2012 to 
2016 varied. Among females, the preva-
lence was 8.2% in the first year of the 
study, then the rates dropped to 6.3% 
and 6.0% in 2013 and 2014 respectively, 
then the rates increased to 11.6% and 
12.2% in 2015 and 2016 respectively. 
Among the male participants, the prev-
alence rates increased steadily from 
2012 to 2014, but decreased in 2015 
and 2016, with rates of 91.8% in the 
first year and 87.8% in the fifth year. 
These findings are presented in table 
2 and figure 1 respectively. The preva-
lence trend shows a statistically signifi-
cant change (χ2 = 51.764, p = < 0.001) as 
depicted in table 3.
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Table 2. Gender Comparison of Five-Year Prevalence Trend of Substance Use Disorder
Year Females n(%) Males n(%) Total n(%)
N = 2731
2012 42(8.2) 473(91.8) 515(18.9)
2013 31(6.3) 462(93.7) 493(18.0)
2014 26(6.0) 406(94.0) 432(15.8)
2015 68(11.6) 519(88.4) 587(21.5)
2016 86(12.2) 618(87.8) 704(25.8)
Total 253(9.3) 2478(90.7) 2751(100.0)
Figure 1. Comparative Five-Year Prevalence Trend Between Males and Females
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Clinical Profiles of the Study Participants
The average age of onset of psychoac-
tive substance use among the subjects is 
24.45 + 3.72 years, with a range of 12 to 
56 years. Peer group pressures and use 
out of curiosity were the commonest 
‘push factors’ for initiation while Codeine-
containing cough syrup (CCCS), Tramadol, 
and Benzodiazepines were the most com-
monly used substances. Over 65% of the 
participants also met the ICD-10 diagnos-
tic criteria for dependence (table 4).
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2012 515 42 8.2 51.764 <0.001**
2013 493 31 6.3
2014 432 26 6.0
2015 587 68 11.6
2016 704 86 12.2
Table 4. Clinical Parameters of the Female Study Participants
Variable Frequency (%) 95% C.I.
N = 253
Age in years at onset of drug use [Mean =24.45+3.72 SD, Range = 12-56]
<18 42(16.6) 10.26 - 24.77
18 - 27 126(49.8) 39.97 - 58.46
28 - 37 66(26.1) 22.91 - 35.72
38 - 47 17(6.7) 3.66 - 11.54
48 - 57 2(0.8) 0.27 - 1.44
> 58 0(0.0) -
Mode(s) of initiation
Peer group influence 149(58.9) 47.61 - 72.58
By a partner 17(6.7) 3.33 - 10.54
Prescribed by a health worker 17(6.7) 3.73 - 9.47
Out of curiosity 44(17.4) 10.89 - 24.17
Others 26(10.3) 5.67 - 14.13
Type(s) of psychoactive substance used
Alcohol 8(3.2) 1.66 - 6.52
Shisha 26(10.3) 6.14 - 18.33
Cannabis 17(6.7) 3.51 - 10.72
Cough Syrup with codeine (CCCS) 73(28.8) 22.18 - 42.27
Jankee 23(9.1) 6.18 - 16.19
Benzodiazepine 31(12.2) 8.54 - 18.76
Pentazocine 5(2.0) 1.20 - 2.94
Cocaine 1(0.4) 0.12 - 0.83
Tramadol 41(16.2) 10.24 - 25.18
Multiple Psychoactive Substances 18(7.1) 4.77 - 12.21
Other 10(4.0) 2.12 - 6.70
Met ICD-10 Criteria for Dependence
Yes 165(65.2) 45.81 - 79.45
No 88(34.8) 30.15 - 41.56
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Modes of Presentations of Female 
Psychoactive Substance Users
The major modes of presentation of 
the clients to the facility were: compul-
sion by relatives to present 40.7% (n = 
103), incidental finding 22.92% (n = 58), 
and because of the occurrence intoler-
able withdrawal symptoms 14.62% (n = 
37) (table 5).
DISCUSSION
This study assessed the prevalence and 
patterns of psychoactive drug use among 
females in North-eastern Nigeria, the 
changing annual prevalence trend over a 
five year duration, and the modes of pre-
sentation of the study participants. This is 
informed by the growing public concerns 
and the public health implications of the 
raging psychoactive drug use epidemic 
in the country in general, and the North-
east sub-region in particular.
The sociodemographic characteristics 
of the female drug users revealed, over 
two-third of them fall between 18 to 
37 years, with an average age of onset 
of drug usage of 24.45 years, while just 
about a quarter were above 37 years with 
fewer subjects above 58 years of age. This 
is consistent with the findings of earlier 
studies by Gureje et al., (2007), Alti-Mua-
zu and Aliyu, (2008), Dankani, (2013), & 
Adamson et al., (2015), in different parts 
of the country that have all demonstrated 
prevalent use of psychoactive substances 
among subjects below 40 years of age. 
This could be attributed to the socializa-
tion process, stressors encountered and 
the curiosity exhibited by the young adults 
as posited by Boys, et al., (2001), Musick, 
et al., (2008), Calcaterra, et al., (2014), as 
well as Pavarin & Consonni, (2013). 
In terms of their educational levels 
and occupational status, most of the fe-
male drug users had less than 12 years of 
education and an overwhelming major-
ity of them (>70%) were either unskilled 
workers or unemployed. This is in tan-
dem with the findings of earlier studies 
by Badel & Greaney, (2013), Dankani, 
(2014), and Ibrahim, et al., (2017). This 
relationship could be explained by the 
obvious relationship between low edu-
cation and employment status, as well 
as by the negative effect of psychoactive 
drugs on educational attainment and ca-
reer progression. Like in some previous 
studies by Dankani, (2012) and Ibrahim, 
et al., (2015) in similar settings, most of 
study participants (>95%) were either 
single or divorced. This could be attribut-
ed to the stigmatizing effects of feminine 
drug abuse or the inability of the drug 
users to settle and establish a secured 
relationship. 
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Table 5. Mode(s) of Presentation of Female Psychoactive Drug Users to the Facility
Mode of Presentation Frequency (%) 95% C.I.
N = 253
Involuntary (Compelled by Relatives) 103(40.71) 29.46 - 53.17
Voluntarily 22(8.71) 5.18 - 11.24
Incidental (Acute Psychotic Episode) 58(22.92) 15.75 - 28.93
Intolerable withdrawal symptoms 37(14.62) 10.27 - 19.52
Referred from other sources 33(13.04) 8.06 - 11.59
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In terms of the prevalence trends of 
drug abuse among the female subjects, 
the overall prevalence for the five year 
duration was 9.3%, but the rate at the in-
ception of the study was -8.2% in 2012, 
which declined to 6.3% and 6.0% in 2013 
and 2014 respectively. This then increased 
to 11.6% in 2015 and 12.2% in 2016. This 
was indicative of a rising trend, but the 
transient decline in 2013 and 2014 could 
be due to the raging ‘Boko Haram insur-
gency’ which coincided with the peak of 
the insecurity. This might have restricted 
the access to mental health care particu-
larly by the womenfolk. The rising preva-
lence rates thereafter, could be attrib-
uted to the escalating wave of abuse of 
psychoactive substances, most especially 
Codeine-containing cough syrup (CCCS) 
by young adults (especially females) and 
Tramadol in Northern Nigeria which were 
earlier reported by Dankani, (2012), and 
Ibrahim, et al., (2017). This could be due 
to ready availability and accessibility to 
the drugs without much control on the 
part of regulatory and enforcement agen-
cies. The other probable reason for the 
increased prevalence among the female 
subjects might be due to increased men-
tal health seeking behaviour due to the 
health promotion programmes sponsored 
by the institution on local radio channels. 
The prevalence trend of the male subjects 
was directly opposite to that of the fe-
males which is reflective of the changing 
gender trend.
Regarding the clinical profiles of the 
study participants, most of the sub-
jects were initiated into psychoactive 
substance use due to peer group pres-
sure and out of curiosity to know how it 
feels to take the drug. This is consistent 
with the outcomes of previous studies 
by Reed and Rountree, (1997), and by 
Simons-Morton and Farhat, (2010). A pe-
culiar method of initiation noted in the 
female subjects in this study, is that by 
partners in intimate relationships which 
has also been reported by Fleming, et al., 
(2010). The three commonest psychoac-
tive substances used by the subjects were 
codeine-containing cough syrup (CCCS) 
reported in over a quarter of the them, 
Tramadol reported in over 16% of the 
subjects, and Benzodiazepines reported 
in 12% of them. This finding supports 
earlier assertion by the Substance Abuse 
and Mental Health Services Adminis-
tration (SAMHSA), (2014) that female 
psychoactive substance users are more 
likely to use Opiates and sedatives while 
their male counterparts that are more 
likely to use alcohol and Cannabis. In ad-
dition, over 7.0% use multiple psychoac-
tive substances. Multiple psychoactive 
substance use is common in the setting 
the study was conducted as reported by 
Gudaji, et al., (2016) in Kano and Ibra-
him, et al., (2017) in Maiduguri. Finally, 
over 65% of the subjects met the ICD-10 
diagnostic criteria for dependence. This 
might not be unconnected with the phe-
nomenon of ‘telescoping’ which posits 
that women develop features of depen-
dence at a faster rate when compared to 
their male counterparts (Brady & Ran-
dall, 1999).
An interesting outcome of this study 
was that less than one-tenth of female 
subjects presented voluntarily to the 
facility for treatment, while over three-
fifth of them were either compelled by 
caregivers or were incidentally found to 
be using psychoactive substances when 
they presented with acute psychotic epi-
sodes. This is pertinent, considering the 
fact that self-efficacy and optimal moti-
vation as indicated by the willingness to 
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present self for treatment is a positive 
prognostic indicator as posited by Ciraulo, 
et al., (2003), and Gau, et al., (2007) in 
the management of substance use disor-
ders. The factors possibly responsible for 
the high rate of involuntary presentation 
include; stigmatization of mental illness, 
most especially feminine drug use, and 
the misconceptions about the aetiology 
of mental illnesses which are still being 
viewed from the supernatural perspec-
tive in most sub-Saharan African settings 
as reported by Adebowale and Ogunlesi, 
(1999); Kabir, et al., (2004); Isa, et al., 
(2008); Adewuya, et al., (2008); Audu, 
et al., (2011); Sheikh, et al., (2015); and 
Armiya’u, et al., (2015).
Strength and Limitations of the Study
This is the first study that attempts to 
answer the question of psychoactive sub-
stance use exclusively among females in 
northern Nigeria based on available liter-
ature, while the limitations include: (i) it is 
a hospital-based study, therefore, it might 
not be a true reflection societal problem 
since most patients do not present to the 
facility for the fear of being stigmatized (ii) 
causal inference cannot be made because 
of the cross sectional nature of the study.
Conclusion and Recommendations
This study revealed that there is a rising 
prevalence trend in the use of psychoac-
tive substances among females, especial-
ly those in the 18 to 37 years age brack-
et in Northeastern Nigeria. Peer group 
pressure, curiosity and induction by a 
partner were the most common meth-
ods of initiation into drug use, and that 
CCCS and Benzodiazepines were the most 
common substances of abuse with over 
60% of them meeting the criteria for de-
pendence. The rate of voluntary hospital 
presentation is abysmally low. These 
findings have some policy implications. 
The authors, therefore, recommend the 
designing of culturally appropriate and 
gender-specific educational programmes 
that will mitigate the escalating scourge. 
Secondly, the operational capacities of 
control agencies should be enhanced to 
effectively implement drug demand re-
duction strategies as contained in existing 
policies. Thirdly, stigma-reduction strat-
egies associated with female drug use 
should be implemented through massive 
community mobilization via social and 
conventional media outlets.
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